Skip to main content

U.S. Bet Big on Covid Vaccine Manufacturer Even as Problems Mounted

The Baltimore plant that recently had to scrap up to 15 million ruined doses had flouted rules and downplayed errors, according to internal audits, ex-employees and clients. Other doses had to be scrapped last year.
U.S. Bet Big on Covid Vaccine Manufacturer Even as Problems Mounted  image

U.S. Bet Big on Covid Vaccine Manufacturer Even as Problems Mounted - The New York Times

The Baltimore plant that recently had to scrap up to 15 million ruined doses had flouted rules and downplayed errors, according to internal audits, ex-employees and clients. Other doses had to be scrapped last year.
Read More

In Similar Category

From New York Times